A synthetic peptide for use as a blocking control in assays to test for specificity of BRD4 antibody, Alternative Names: BRD4 control peptide, BRD4 antibody Blocking Peptide, Anti-BRD4 Blocking Peptide, bromodomain containing 4 Blocking Peptide, CAP Blocking Peptide, HUNKI Blocking Peptide, MCAP Blocking Peptide, BRD4, BRD-4, BRD 4, BRD-4 Blocking Peptide, BRD 4 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
BRD4
(Bromodomain Containing 4 (BRD4))
Hintergrund
BRD4 is homologous to the murine protein MCAP, which associates with chromosomes during mitosis, and to the human RING3 protein, a serine/threonine kinase. Each of these proteins contains two bromodomains, a conserved sequence motif which may be involved in chromatin targeting.